Nanobiotix S.A.
NBTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $130,998 | $242,104 | $119,452 | $247,411 |
| - Cash | $49,737 | $75,283 | $41,388 | $83,921 |
| + Debt | $50,902 | $50,565 | $53,168 | $46,020 |
| Enterprise Value | $132,163 | $217,386 | $131,232 | $209,510 |
| Revenue | -$11,609 | $36,208 | $4,776 | $2,647 |
| % Growth | -132.1% | 658.1% | 80.4% | – |
| Gross Profit | -$11,609 | $36,208 | $3,791 | $2,647 |
| % Margin | 100% | 100% | 79.4% | 100% |
| EBITDA | -$58,324 | -$23,686 | -$44,217 | -$45,605 |
| % Margin | 502.4% | -65.4% | -925.8% | -1,722.9% |
| Net Income | -$68,132 | -$39,700 | -$57,043 | -$47,004 |
| % Margin | 586.9% | -109.6% | -1,194.4% | -1,775.7% |
| EPS Diluted | -1.44 | -1.08 | -1.64 | -1.35 |
| % Growth | -33.3% | 34.1% | -21.5% | – |
| Operating Cash Flow | -$19,551 | -$12,476 | -$37,104 | -$29,872 |
| Capital Expenditures | -$848 | -$337 | -$93 | -$233 |
| Free Cash Flow | -$20,399 | -$12,813 | -$37,197 | -$30,105 |